The utilisation is coming back
Q4 missed slightly on sales and adj. EBITA compared with consensus' expectations. Organically, sales declined ~12% and the adj. EBITA margin was ~4.5%, which is low compared to historical levels. That said, utilisation is on the rise again, partly thanks to a reduction of FTEs with zero to low utilisation rates, but also thanks to an underlying improvement as B3 has been managing the worsened conditions in the last two years.